Wenting Cheng, Biogen
Established in 2018, the ASA Biopharmaceutical Section Scholarship Award recognizes notable research, academic achievement, and applied project work in biopharmaceutical statistics. The award also considers general academic performance, leadership, volunteering, and service.
The following 10 students were awarded the ASA Biopharmaceutical Section Award in 2024:
- Navneet Ram Hakhu from the University of California, Irvine, will join the department of biostatistics at Harvard T.H. Chan School of Public Health as a postdoctoral research fellow to work on statistical methods at the intersection of randomized trials and observational studies.
- Ann Marie Weideman from The University of North Carolina at Chapel Hill will work at Eli Lilly in Indianapolis as a research adviser statistician in the diabetes group.
- Ransmond Berchie from the University of Utah will seek a biostatistician role in the biotech/biopharmaceutical industry after completing their degree in spring 2025.
- Megan McCabe from the University of Iowa will join the school of public health at the University of Alabama at Birmingham as an assistant professor.
- Yixin (Amy) Zhang from Boston University will work as an independent researcher and focus on statistical genetics and omics with the goal of making contributions to the biopharmaceutical field through work such as identifying biomarkers that may be potential therapeutic targets.
- Dennis Baidoo from the University of New Mexico hope to become a leading researcher and educator, contributing to the development of advanced statistical methodologies that drive breakthroughs in biomedical research, public health, and clinical practice. He also aims to secure a faculty position.
- Runjia Li from the University of Pittsburgh will join Eli Lilly as a research adviser after graduation.
- Marlena Bannick from the University of Washington will focus on methodological and applied work in the design, conduct, and analysis of clinical trials.
- Lizhao Ge from The George Washington University will explore various opportunities in the biopharmaceutical industry and with the US Food and Drug Administration.
- Zhongyang Ma from New York University plans to work as a biostatistician in the biopharmaceutical industry and engage in the planning, methodology, and analysis of clinical trials.
The number of submissions doubled from last year and, due to the increase in and quality of submissions, the committee—composed of Wenting Cheng, Bruce Binkowitz, Rebecca Wilson, and Tony Jiang—received approval to distribute $30,000 across 10 awards.
The 2024 honorees were formally recognized at the Biopharmaceutical Section’s open business meeting during the 2024 Joint Statistical Meetings.
Leave a Reply